Literature DB >> 12496371

c-Cbl-dependent EphA2 protein degradation is induced by ligand binding.

Jennifer Walker-Daniels1, David J Riese, Michael S Kinch.   

Abstract

The EphA2 receptor protein tyrosine kinase is overexpressed and functionally altered in a large number of human carcinomas. Despite its elevated levels in cancer, the EphA2 on the surface of malignant cells demonstrates lower levels of ligand binding and tyrosine phosphorylation than the EphA2 on non-transformed epithelial cells. In our present study, we demonstrate that ligand-mediated stimulation causes EphA2 to be internalized and degraded. The mechanism of this response involves ligand-mediated autophosphorylation of EphA2, which promotes an association between EphA2 and the c-Cbl adaptor protein. We also show that c-Cbl promotes stimulation-dependent EphA2 degradation. These findings are important for understanding the causes of EphA2 overexpression in malignant cells and provide a foundation for investigating EphA2 as a potential target for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12496371

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  73 in total

Review 1.  Differential regulation of EphA2 in normal and malignant cells.

Authors:  Jennifer Walker-Daniels; Angela R Hess; Mary J C Hendrix; Michael S Kinch
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

2.  Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2.

Authors:  Masamitsu Tanaka; Riuko Ohashi; Ritsuko Nakamura; Kazuya Shinmura; Takaharu Kamo; Ryuichi Sakai; Haruhiko Sugimura
Journal:  EMBO J       Date:  2004-02-26       Impact factor: 11.598

3.  Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection.

Authors:  Sayan Chakraborty; Mohanan Valiya Veettil; Virginie Bottero; Bala Chandran
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

4.  The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus.

Authors:  Alexander S Hahn; Johanna K Kaufmann; Effi Wies; Elisabeth Naschberger; Julia Panteleev-Ivlev; Katharina Schmidt; Angela Holzer; Martin Schmidt; Jin Chen; Simone König; Armin Ensser; Jinjong Myoung; Norbert H Brockmeyer; Michael Stürzl; Bernhard Fleckenstein; Frank Neipel
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

5.  Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis.

Authors:  R Holm; S Knopp; Z Suo; C Tropè; J M Nesland
Journal:  J Clin Pathol       Date:  2006-12-08       Impact factor: 3.411

6.  Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.

Authors:  Roberta Noberini; Mitchell Koolpe; Satyamaheshwar Peddibhotla; Russell Dahl; Ying Su; Nicholas D P Cosford; Gregory P Roth; Elena B Pasquale
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

7.  Activation of EphA receptors mediates the recruitment of the adaptor protein Slap, contributing to the downregulation of N-methyl-D-aspartate receptors.

Authors:  Sophia Semerdjieva; Hayder H Abdul-Razak; Sharifah S Salim; Rafael J Yáñez-Muñoz; Philip E Chen; Victor Tarabykin; Pavlos Alifragis
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

Review 8.  The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.

Authors:  Jill Wykosky; Waldemar Debinski
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

9.  Screening for EphB signaling effectors using SILAC with a linear ion trap-orbitrap mass spectrometer.

Authors:  Guoan Zhang; David Fenyö; Thomas A Neubert
Journal:  J Proteome Res       Date:  2008-09-25       Impact factor: 4.466

10.  Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.

Authors:  Wei Bin Fang; Dana M Brantley-Sieders; Yoonha Hwang; Amy-Joan L Ham; Jin Chen
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.